Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony Evnin Insider Profile
11 Followers
Anthony Evnin, Director at Juno Therapeutics, holds 0.00 shares in AVEO Pharma (Ticker: AVEO), holds 215.40K shares in Infinity Pharmaceuticals (Ticker: INFIQ), holds 12.13K shares in Cantel Medical (Ticker: CMD).
Profitable Transactions
5 out of 12 Profitable Transactions
Average Return
+38.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anthony Evnin holds in companies
Most Profitable Insider Trade
Stock:
Juno Therapeutics
(JUNO)
(JUNO)
Rating:Informative Buy
Date:Mar 13, 2017 - Mar 13, 2018
Return:+275.00%
The most profitable trade made by Anthony Evnin
Anthony Evnin's Trading History
Juno Therapeutics
Mar 07, 2018
―
Uninformative Sell
―
$0.00
Cantel Medical
Jul 31, 2020
―
Uninformative Buy
―
$975.05K
Constellation Pharmaceuticals
Dec 16, 2019
―
Informative Buy
13.80M
$195.20M
AVEO Pharma
Jan 19, 2023
―
Uninformative Sell
627.62K
$0.00
Infinity Pharmaceuticals
Jun 16, 2022
Director
Uninformative Buy
31.07K
$3.45K
Acceleron Pharma
Sep 26, 2013
―
Uninformative Buy
―
$446.19M
Viracta Therapeutics
―
Director
―
$20.21K
List of latest transactions for each holding click on a transaction to see Anthony Evnin's performance on stock
You May Also Like
Anthony Evnin insider profile FAQ
What is the percentage of profitable transactions made by Anthony Evnin?
The percentage of profitable transactions made by Anthony Evnin is 42%.
What is the average return per transaction made by Anthony Evnin?
The average return per transaction made by Anthony Evnin is 38.50%.
What stocks does Anthony Evnin hold?
Anthony Evnin holds: JUNO, CMD, CNST, AVEO, INFIQ, XLRN, VIRX stocks.
What was Anthony Evnin’s latest transaction?
Anthony Evnin latest transaction was an Uninformative Sell of $627.62K.
What was Anthony Evnin's most profitable transaction?
Anthony Evnin’s most profitable transaction was an Informative Buy of JUNO stock on March 13, 2017. The return on the trade was 275.00%.
What is Anthony Evnin's role in Juno Therapeutics?
Anthony Evnin's role in Juno Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.